SCOTTSDALE, Ariz., May 23, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will participate in the following upcoming investor conferences.
UBS Healthcare Services Cape Cod Summit
Participants: Dave Bourdon, CFO, and Monica Prokocki, VP of Finance and Investor Relations
Date: Tuesday, June 4, 2024
Location: Chatham Bars Inn, Chatham, MA
Note: No presentation due to event format; investor meetings only
Goldman Sachs 45th Annual Healthcare Conference
Presenters: Dave Bourdon, CFO, and Monica Prokocki, VP of Finance and Investor Relations
Date: Monday, June 10, 2024
Location: Loews Miami Beach Hotel, Miami Beach, FL
Time: 10:00 a.m. (Eastern time)
Moderated by: Jamie Perse
If applicable, the presentation will be webcast live, and a replay will be made available following the event, on the Investor Relations section of LifeStance’s website at https://investor.lifestance.com.
About LifeStance Health
Founded in 2017, LifeStance (NASDAQ: LFST) is reimagining mental health. We are one of the nation’s largest providers of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Our mission is to help people lead healthier, more fulfilling lives by improving access to trusted, affordable and personalized mental health care. LifeStance and its supported practices employ approximately 6,800 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers. To learn more, please visit www.LifeStance.com.
Last Trade: | US$7.44 |
Daily Change: | 0.15 2.06 |
Daily Volume: | 555,338 |
Market Cap: | US$2.850B |
November 20, 2024 November 07, 2024 August 21, 2024 August 08, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB